MILAN, Oct. 9, 2025 /PRNewswire/ -- ZTE Corporation (0763.HK / 000063.SZ), a global leading provider of integrated information and communication technology solutions, hosted the Global Summit & User Congress 2025...
Read moreMILAN, Oct. 9, 2025 /PRNewswire/ -- ZTE Corporation (0763.HK / 000063.SZ), a global leading provider of integrated information and communication technology solutions, hosted the Global Summit & User Congress 2025...
Read morePARIS, Oct. 9, 2025 /PRNewswire/ -- With Frieze London about to kick off, followed by Art Basel Paris, Artprice News® announces the release of its 31st Contemporary Art Market Annual...
Read morePARIS, Oct. 9, 2025 /PRNewswire/ -- With Frieze London about to kick off, followed by Art Basel Paris, Artprice News® announces the release of its 31st Contemporary Art Market Annual...
Read more- Driving the next wave of AI innovation through high-performance inference at the edge SINGAPORE, Oct. 9, 2025 /PRNewswire/ -- Zenlayer, the world's first hyperconnected cloud, today announced the launch...
Read moreSingPost to support schools with starter kits to kickstart the Young Philatelists School Programme Sengkang Green Primary School set to pilot Young Philatelist programme using philately as a medium of...
Read moreSingPost to support schools with starter kits to kickstart the Young Philatelists School Programme Sengkang Green Primary School set to pilot Young Philatelist programme using philately as a medium of...
Read moreMILAN, Oct. 9, 2025 /PRNewswire/ -- On October 6, ZTE Corporation (0763.HK / 000063.SZ), a global leading provider of integrated information and communication technology solutions, presented its dual-pillar strategy for global expansion: 2C transformation...
Read moreMILAN, Oct. 9, 2025 /PRNewswire/ -- On October 6, ZTE Corporation (0763.HK / 000063.SZ), a global leading provider of integrated information and communication technology solutions, presented its dual-pillar strategy for global expansion: 2C transformation...
Read moreHANGZHOU, China, Oct. 9, 2025 /PRNewswire/ -- Chance Pharmaceuticals ("Chance" or "Chance Pharma"), a clinical-stage biotechnology company dedicated to the research and development of innovative inhalation therapies, today announced that...
Read more
